Stock ZYXI ZYNEX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Zynex, Inc.

Equities

ZYXI

US98986M1036

Real-time Estimate Cboe BZX
Other stock markets
 14:08:58 2024-05-09 EDT 		5-day change 1st Jan Change
10.69 USD -0.37% Intraday chart for Zynex, Inc. -7.11% -1.56%
04-30 Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on February 29, 2024. CI
04-30 Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023. CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on February 29, 2024.
CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.
CI
Earnings Flash (ZYXI) ZYNEX Posts Q1 Revenue $46.5M, vs. Street Est of $47.7M
MT
Zynex, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Reaffirms for the Full Year 2024
CI
Zynex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Zynex, Inc.'s Equity Buyback announced on November 1, 2023, has closed with 1,900,020 shares, representing 5.64% for $20 million.
CI
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024
CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.
CI
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.
CI
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.
CI
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M
MT
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Zynex, Inc. authorizes a Buyback Plan.
CI
Zynex, Inc. Introduces New Products
CI
Zynex Receives US FDA Approval for Muscle Stimulation Device
MT
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device
CI
Zynex, Inc.'s Equity Buyback announced on September 11, 2023, has closed with 1,204,239 shares, representing 3.43% for $10 million.
CI
Zynex, Inc. Submits FDA Application for Its NMES Device
CI
Zynex to Repurchase Up to $20 Million Common Shares Through Nov. 1, 2024
MT
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZYXI Stock
  4. News Zynex, Inc.
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW